Biotechblog – Page 1047 – Biotechnology business, policy, and more!

Career Development at UNC Chapel Hill

I’ll be giving a talk on career development in biotechnology at UNC-Chapel Hill on Wednesday May 16th at 4pm in […]

What does Greenpeace oppose more: Patents, or genetic modification? This question has been answered in a recent patent case where

My article on the top five biotechnology blogs is up at Biotech360. Hope I don’t get too much hatemail over

India’s biotechnology industry has the potential to become a major driver of the country’s economy, but is challenged by one

I’ve been asked quite a bit recently to talk about my career path. I usually begin my talks by explaining

I previously posted how price controls and compulsory licensing give buyers more power … for a price and Abbott’s spat

Coming soon, a new biotechnology magazine from The Scientist called Biotech 360. I’ve been asked to compile a list of

In response to Thailand’s decision to issue compulsory licenses for Kaletra and for Plavix, effectively bypassing their patents by purchasing

Welcome to the April 10, 2007 edition of Carnival of Biotechnology. Finance and business development On Pharma presents a report

I’ll be giving a talk at UC Davis from April 19-20th and UNC Chapel Hill from May 16-17th. If you’re